Cognex (CGNX) director logs stock sale and RSU conversion in Form 4 filing

Rhea-AI Filing Summary

Cognex Corp director Angelos Papadimitriou reported a mix of stock transactions. On February 23, 2026, he sold 4,150 shares of common stock in an open-market transaction at an average price of $55.5804 per share, leaving 16,222 common shares directly owned.

On February 21, 2026, restricted stock units covering 2,537 shares were exercised and converted into the same number of common shares at no cash exercise price, increasing his common stock before the sale to 20,372 shares. Following these transactions, he also directly holds 4,817 restricted stock units that vest over time under a prior grant.

Insider Trade Summary

Net Seller: 4,150 shares ($230,659)

Net Sell 4 txns

Insider Papadimitriou Angelos

Role Director

Sold 4,150 shs ($231K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,150	$55.5804	$231K
Exercise	Restricted Stock Unit	2,537	$0.00	--
Exercise	Common Stock	2,537	$0.00	--
holding	Restricted Stock Unit	--	--	--

Holdings After Transaction: Common Stock — 16,222 shares (Direct); Restricted Stock Unit — 0 shares (Direct)

Footnotes (1)

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Papadimitriou Angelos

(Last) (First) (Middle)

1 VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/21/2026		M		2,537	A	$0.0	20,372	D
Common Stock	02/23/2026		S		4,150	D	$55.5804	16,222	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.0(1)	02/21/2026		M			2,537	02/21/2024(2)	02/21/2026	Common Stock	2,537	$0.0	0	D
Restricted Stock Unit	$0.0							02/17/2027	02/17/2027	Common Stock	4,817		4,817	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

2. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.

	Angelos Papadimitriou	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Cognex (CGNX) director Angelos Papadimitriou report?

Angelos Papadimitriou reported selling 4,150 Cognex common shares and exercising restricted stock units for 2,537 shares. These transactions combined an open-market sale with a non-cash conversion of equity awards into common stock on separate February 2026 dates.

How many Cognex (CGNX) shares did the director sell and at what price?

He sold 4,150 Cognex common shares at an average price of $55.5804 per share. This open-market transaction on February 23, 2026 reduced his directly owned common stock position to 16,222 shares after the sale.

What equity awards did the Cognex (CGNX) director convert into common stock?

On February 21, 2026, 2,537 restricted stock units were exercised and converted into 2,537 Cognex common shares at a stated price of $0.0000. This reflects a non-cash derivative conversion of previously granted equity awards into stock.

How many Cognex (CGNX) shares and RSUs does the director hold after these transactions?

After the reported transactions, the director directly owns 16,222 Cognex common shares and 4,817 restricted stock units. The RSUs continue to represent contingent rights to receive shares as they vest according to their original grant schedule.

What do the Cognex (CGNX) restricted stock unit footnotes explain?

The footnotes explain that each restricted stock unit equals one Cognex common share and that the units vest 20%, 30%, and 50% on the first, second, and third anniversaries of the February 21, 2023 grant date, subject to the original award terms.